[The age of artificial intelligence in lung cancer pathology: Between hope, gloom and perspectives].
La pathologie cancéreuse pulmonaire à l’heure de l’intelligence artificielle : entre espoir, désespoir et perspectives.
Apprentissage profond
Artificial intelligence
Cancer broncho-pulmonaire
Convolutional neural networks
Deep learning
Histologie
Histology
Intelligence artificielle
Lung cancer
Pathologie
Pathology
Réseaux de neurones convolutifs
Journal
Annales de pathologie
ISSN: 0242-6498
Titre abrégé: Ann Pathol
Pays: France
ID NLM: 8106337
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
15
12
2018
accepted:
16
01
2019
pubmed:
18
2
2019
medline:
20
12
2019
entrez:
18
2
2019
Statut:
ppublish
Résumé
Histopathology is the fundamental tool of pathology used for more than a century to establish the final diagnosis of lung cancer. In addition, the phenotypic data contained in the histological images reflects the overall effect of molecular alterations on the behavior of cancer cells and provides a practical visual reading of the aggressiveness of the disease. However, the human evaluation of the histological images is sometimes subjective and may lack reproducibility. Therefore, computational analysis of histological imaging using so-called "artificial intelligence" (AI) approaches has recently received considerable attention to improve this diagnostic accuracy. Thus, computational analysis of lung cancer images has recently been evaluated for the optimization of histological or cytological classification, prognostic prediction or genomic profile of patients with lung cancer. This rapidly growing field constantly demonstrates great power in the field of computing medical imaging by producing highly accurate detection, segmentation or recognition tasks. However, there are still several challenges or issues to be addressed in order to successfully succeed the actual transfer into clinical routine. The objective of this review is to emphasize recent applications of AI in pulmonary cancer pathology, but also to clarify the advantages and limitations of this approach, as well as the perspectives to be implemented for a potential transfer into clinical routine.
Identifiants
pubmed: 30772062
pii: S0242-6498(19)30019-7
doi: 10.1016/j.annpat.2019.01.003
pii:
doi:
Types de publication
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
130-136Informations de copyright
Copyright © 2019 Elsevier Masson SAS. All rights reserved.